The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

@article{Sindrup1990TheSS,
  title={The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms},
  author={S. Sindrup and L. F. Gram and K. Br{\o}sen and O. Esh{\o}j and E. Mogensen},
  journal={Pain},
  year={1990},
  volume={42},
  pages={135-144}
}
  • S. Sindrup, L. F. Gram, +2 authors E. Mogensen
  • Published 1990
  • Medicine
  • Pain
  • &NA; The effect of the selective serotonin reuptake inhibitor paroxetine on diabetic neuropathy symptoms was examined in comparison to imipramine and placebo in a randomised, double‐blind, cross‐over study. Paroxetine was given as a fixed dose of 40 mg/day, while the dose of imipramine was adjusted to yield optimal plasma levels of imipramine plus desipramine of 400–600 nM. Paroxetine significantly reduced the symptoms of neuropathy as measured by both observer‐ and self‐rating, but was… CONTINUE READING
    427 Citations
    Lack of effect of mianserin on the symptoms of diabetic neuropathy
    • 34

    References

    SHOWING 1-10 OF 29 REFERENCES
    Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
    • 88
    • PDF
    Pain Relief in Diabetic Neuropathy: The Effectiveness of Imipramine and Related Drugs
    • R. Young, B. Clarke
    • Medicine
    • Diabetic medicine : a journal of the British Diabetic Association
    • 1985
    • 84